Abbott Medical Devices
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Abbott Medical Devices sits in the top decile of US sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count).
Abbott Medical Devices: 261 sponsored US clinical trials, 23 recruiting.
Abbott Medical Devices sponsors 261 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 186 completed. 17 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 15 trials.
Top-decile sponsor footprint
Abbott Medical Devices ranks in the top decile of sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
186 of 211 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
261 total, page 6 of 6
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
NCT00121485
Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients
NCT00187200
Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE
NCT00180492
PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions
NCT00180466
Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER
NCT00578708
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
NCT00465270
Feasibility Study of a Percutaneous Mitral Valve Repair System.
NCT00209339
Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
NCT00583791
Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease
NCT00180544
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
NCT00583596
Artificial Valve Endocarditis Reduction Trial
NCT00590889
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
| Phase 3 | 11 |
| Phase 4 | 6 |
Therapeutic Areas
Where Abbott Medical Devices enrollment is open (later-stage tilt)
23 recruiting of 261 indexed (9% open); 186 completed (71%).
Phase mix: 17 late (III/IV) vs 5 early (I/II) (later-stage heavy).
Top condition: Heart Failure (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Abbott Medical Devices: open-pipeline peers nationwide
Peers matched on 261 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 261 trials (± recruiting share)
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
- Novartis · 265 trials · 0% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Boston Medical Center · 253 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Grifols Therapeutics · 9% recruiting · 34 trials
- Butler Hospital · 9% recruiting · 103 trials
- AMAG Pharmaceuticals · 9% recruiting · 23 trials
- Iowa State University · 9% recruiting · 23 trials
Related
What to do with this Abbott Medical Devices page
261 registered trials is a research-attention snapshot, not an endorsement of Abbott Medical Devices or any single study.
- 23 of Abbott Medical Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Abbott Medical Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Abbott Medical Devices pipeline card: 261 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.